Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol route comparison for reduction of cesarean bleeding
IRCT20200501047257N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of misoprostol and oxytocin (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Bleeding during cesarean section. Started May 2020; status: completed.
02
Drugs
misoprostoloxytocin
Beyond the preview
Go deeper on IRCT20200501047257N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200501047257N1.